Comparison of ampicillin-sulbactam regimens simulating 1.5- and 3.0-gram doses to humans in treatment of Escherichia coli bacteremia in mice.
about
Pharmacodynamics of ampicillin-sulbactam in an in vitro infection model against Escherichia coli strains with various levels of resistance.Efficacy of ampicillin-sulbactam is not dependent upon maintenance of a critical ratio between components: sulbactam pharmacokinetics in pharmacodynamic interactions.Efficacy of ceftobiprole Medocaril against Enterococcus faecalis in a murine urinary tract infection model
P2860
Comparison of ampicillin-sulbactam regimens simulating 1.5- and 3.0-gram doses to humans in treatment of Escherichia coli bacteremia in mice.
description
1995 nî lūn-bûn
@nan
1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Comparison of ampicillin-sulba ...... ichia coli bacteremia in mice.
@ast
Comparison of ampicillin-sulba ...... ichia coli bacteremia in mice.
@en
type
label
Comparison of ampicillin-sulba ...... ichia coli bacteremia in mice.
@ast
Comparison of ampicillin-sulba ...... ichia coli bacteremia in mice.
@en
prefLabel
Comparison of ampicillin-sulba ...... ichia coli bacteremia in mice.
@ast
Comparison of ampicillin-sulba ...... ichia coli bacteremia in mice.
@en
P2860
P356
P1476
Comparison of ampicillin-sulba ...... ichia coli bacteremia in mice.
@en
P2093
P2860
P304
P356
10.1128/AAC.39.4.930
P407
P577
1995-04-01T00:00:00Z